LifeTech Scientific Corporation
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac P… Read more
LifeTech Scientific Corporation (LFTSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.105x
Based on the latest financial reports, LifeTech Scientific Corporation (LFTSF) has a cash flow conversion efficiency ratio of 0.105x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($391.27 Million) by net assets ($3.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
LifeTech Scientific Corporation - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how LifeTech Scientific Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
LifeTech Scientific Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LifeTech Scientific Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Shentong Valve Co Ltd
SHE:002438
|
0.028x |
|
Guangdong Tapai Group Co Ltd
SHE:002233
|
0.014x |
|
Protector Forsikring ASA
OTCGREY:PSKRF
|
0.050x |
|
Mani, Inc.
PINK:MNICF
|
N/A |
|
Xiamen Meiya Pico Information
SHE:300188
|
-0.013x |
|
Burke & Herbert Financial Services Corp. Common Stock
NASDAQ:BHRB
|
0.046x |
|
BrightView Holdings
NYSE:BV
|
0.020x |
|
Aguas Andinas S.A
SN:AGUAS-A
|
0.049x |
Annual Cash Flow Conversion Efficiency for LifeTech Scientific Corporation (2010–2024)
The table below shows the annual cash flow conversion efficiency of LifeTech Scientific Corporation from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $3.48 Billion | $321.46 Million | 0.092x | -26.46% |
| 2023-12-31 | $3.32 Billion | $418.05 Million | 0.126x | -5.39% |
| 2022-12-31 | $2.92 Billion | $388.32 Million | 0.133x | -31.20% |
| 2021-12-31 | $2.53 Billion | $488.85 Million | 0.193x | +34.61% |
| 2020-12-31 | $2.36 Billion | $338.53 Million | 0.144x | -39.36% |
| 2019-12-31 | $1.16 Billion | $274.99 Million | 0.237x | +61.52% |
| 2018-12-31 | $1.24 Billion | $182.30 Million | 0.147x | -0.09% |
| 2017-12-31 | $1.06 Billion | $154.89 Million | 0.147x | +0.59% |
| 2016-12-31 | $870.60 Million | $126.96 Million | 0.146x | -81.78% |
| 2015-12-31 | $180.27 Million | $144.31 Million | 0.801x | +540.78% |
| 2014-12-31 | $156.31 Million | $19.53 Million | 0.125x | -15.66% |
| 2013-12-31 | $236.05 Million | $34.96 Million | 0.148x | +4.78% |
| 2012-12-31 | $300.81 Million | $42.52 Million | 0.141x | +221.14% |
| 2011-12-31 | $267.84 Million | $11.79 Million | 0.044x | -99.70% |
| 2010-12-31 | $3.08 Million | $44.76 Million | 14.545x | -- |